ZACCARDELLI DAVID (President and CEO) sold 3.4% of their position (514.15K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $2.25M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/22/2024ACC: 0001104659-24-110659
DirectorOfficer· President and CEO
Since Jan 2021
-514.15K
Net shares
Net seller
$2.25M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
514.15K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−245.78K
Price / share
$4.38
Trade value
$1.08M
% of position
1.6%
10/18/2024
15.25M→15M
Ordinary Shares
Direct
Shares
−110.46K
Price / share
$4.38
Trade value
$483.75K
% of position
0.7%
10/21/2024
15M→14.89M
Ordinary Shares
Direct
Shares
−157.91K
Price / share
$4.39
Trade value
$692.73K
% of position
1.1%
10/22/2024
14.89M→14.74M
Total
Net shares
−514.15K
Net value
-$2.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 10/18/2024 | S · Sale | −245.78K | $4.38 | $1.08M | 1.6% | 15.25M | 15M |
| Ordinary Shares Direct | 10/21/2024 | S · Sale | −110.46K | $4.38 | $483.75K | 0.7% | 15M | 14.89M |
| Ordinary Shares Direct | 10/22/2024 | S · Sale | −157.91K | $4.39 | $692.73K | 1.1% | 14.89M | 14.74M |
| Total | −514.15K | -$2.25M | ||||||
Derivative Transactions0
No derivative transactions reported